{"entity":{"type":"insider","cik":"0001804460","url":"/insider/0001804460","json_url":"/insider/0001804460.json","name":"Paulson Richard A.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":46,"n_filings":42,"first":"2022-05-05","last":"2026-05-15","span_basis":"filed_date"},"name_variants":[{"name":"Paulson Richard A.","source":"filing","n_filings":42,"first_seen":"2022-05-05","last_seen":"2026-05-15"}],"transactions":[{"id":5959526,"accession":"0001193125-26-226613","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-26-226613","line_url":"/filing/0001193125-26-226613#line-2","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001804460","owner_name":"Paulson Richard A.","owner_display_name":"Paulson Richard A.","owner_url":"/insider/0001804460","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2203.0,"shares_display":"2,203","price_per_share":9.5,"price_display":"9.50","price_state":"stated","total_value":20928.5,"total_display":"20,928.50","total_whole":"20,929","shares_owned_after":269747.0,"shares_owned_after_display":"269,747","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-14","filed_date":"2026-05-15","scope":"insider"},{"id":5886751,"accession":"0001804460-26-000003","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001804460-26-000003","line_url":"/filing/0001804460-26-000003#line-1","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001804460","owner_name":"Paulson Richard A.","owner_display_name":"Paulson Richard A.","owner_url":"/insider/0001804460","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12361.0,"shares_display":"12,361","price_per_share":9.4095,"price_display":"9.41","price_state":"stated","total_value":116310.8295,"total_display":"116,310.83","total_whole":"116,311","shares_owned_after":267030.0,"shares_owned_after_display":"267,030","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-02","filed_date":"2026-03-03","scope":"insider"},{"id":4066226,"accession":"0001193125-25-205052","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-25-205052","line_url":"/filing/0001193125-25-205052#line-2","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001804460","owner_name":"Paulson Richard A.","owner_display_name":"Paulson Richard A.","owner_url":"/insider/0001804460","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1257.0,"shares_display":"1,257","price_per_share":6.43,"price_display":"6.43","price_state":"stated","total_value":8082.51,"total_display":"8,082.51","total_whole":"8,083","shares_owned_after":84046.0,"shares_owned_after_display":"84,046","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-15","filed_date":"2025-09-16","scope":"insider"},{"id":4194825,"accession":"0000950170-25-065884","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-065884","line_url":"/filing/0000950170-25-065884#line-1","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001804460","owner_name":"Paulson Richard A.","owner_display_name":"Paulson Richard A.","owner_url":"/insider/0001804460","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":236.0,"shares_display":"236","price_per_share":7.12,"price_display":"7.12","price_state":"stated","total_value":1680.32,"total_display":"1,680.32","total_whole":"1,680","shares_owned_after":82503.0,"shares_owned_after_display":"82,503","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-06","filed_date":"2025-05-07","scope":"insider"},{"id":4059729,"accession":"0000950170-25-051658","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-051658","line_url":"/filing/0000950170-25-051658#line-1","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001804460","owner_name":"Paulson Richard A.","owner_display_name":"Paulson Richard A.","owner_url":"/insider/0001804460","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":245.0,"shares_display":"245","price_per_share":3.74,"price_display":"3.74","price_state":"stated","total_value":916.3,"total_display":"916.30","total_whole":"916","shares_owned_after":82739.0,"shares_owned_after_display":"82,739","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-04-04","filed_date":"2025-04-07","scope":"insider"},{"id":4460872,"accession":"0000950170-25-034736","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-034736","line_url":"/filing/0000950170-25-034736#line-1","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001804460","owner_name":"Paulson Richard A.","owner_display_name":"Paulson Richard A.","owner_url":"/insider/0001804460","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11694.0,"shares_display":"11,694","price_per_share":6.29,"price_display":"6.29","price_state":"stated","total_value":73555.26,"total_display":"73,555.26","total_whole":"73,555","shares_owned_after":82984.0,"shares_owned_after_display":"82,984","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-04","filed_date":"2025-03-06","scope":"insider"},{"id":4130680,"accession":"0000950170-25-014491","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-014491","line_url":"/filing/0000950170-25-014491#line-1","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001804460","owner_name":"Paulson Richard A.","owner_display_name":"Paulson Richard A.","owner_url":"/insider/0001804460","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4099.0,"shares_display":"4,099","price_per_share":0.65,"price_display":"0.65","price_state":"stated","total_value":2664.35,"total_display":"2,664.35","total_whole":"2,664","shares_owned_after":1120158.0,"shares_owned_after_display":"1,120,158","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-04","filed_date":"2025-02-05","scope":"insider"},{"id":4581432,"accession":"0000950170-25-002819","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-002819","line_url":"/filing/0000950170-25-002819#line-1","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001804460","owner_name":"Paulson Richard A.","owner_display_name":"Paulson Richard A.","owner_url":"/insider/0001804460","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4055.0,"shares_display":"4,055","price_per_share":0.783,"price_display":"0.78","price_state":"stated","total_value":3175.065,"total_display":"3,175.06","total_whole":"3,175","shares_owned_after":1124257.0,"shares_owned_after_display":"1,124,257","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-06","filed_date":"2025-01-07","scope":"insider"},{"id":3153021,"accession":"0000950170-24-133689","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-133689","line_url":"/filing/0000950170-24-133689#line-1","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001804460","owner_name":"Paulson Richard A.","owner_display_name":"Paulson Richard A.","owner_url":"/insider/0001804460","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3620.0,"shares_display":"3,620","price_per_share":0.81,"price_display":"0.81","price_state":"stated","total_value":2932.2,"total_display":"2,932.20","total_whole":"2,932","shares_owned_after":1128312.0,"shares_owned_after_display":"1,128,312","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-04","filed_date":"2024-12-05","scope":"insider"},{"id":3152917,"accession":"0000950170-24-122274","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-122274","line_url":"/filing/0000950170-24-122274#line-1","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001804460","owner_name":"Paulson Richard A.","owner_display_name":"Paulson Richard A.","owner_url":"/insider/0001804460","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3675.0,"shares_display":"3,675","price_per_share":0.9106,"price_display":"0.91","price_state":"stated","total_value":3346.455,"total_display":"3,346.46","total_whole":"3,346","shares_owned_after":1131932.0,"shares_owned_after_display":"1,131,932","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-05","filed_date":"2024-11-06","scope":"insider"},{"id":2142906,"accession":"0000950170-24-113263","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-113263","line_url":"/filing/0000950170-24-113263#line-1","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001804460","owner_name":"Paulson Richard A.","owner_display_name":"Paulson Richard A.","owner_url":"/insider/0001804460","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3607.0,"shares_display":"3,607","price_per_share":0.8793,"price_display":"0.88","price_state":"stated","total_value":3171.6351,"total_display":"3,171.64","total_whole":"3,172","shares_owned_after":1135607.0,"shares_owned_after_display":"1,135,607","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-10-04","filed_date":"2024-10-07","scope":"insider"},{"id":2277242,"accession":"0000950170-24-104033","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-104033","line_url":"/filing/0000950170-24-104033#line-1","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001804460","owner_name":"Paulson Richard A.","owner_display_name":"Paulson Richard A.","owner_url":"/insider/0001804460","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3667.0,"shares_display":"3,667","price_per_share":0.7218,"price_display":"0.72","price_state":"stated","total_value":2646.8406,"total_display":"2,646.84","total_whole":"2,647","shares_owned_after":1139214.0,"shares_owned_after_display":"1,139,214","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-04","filed_date":"2024-09-05","scope":"insider"},{"id":2851539,"accession":"0000950170-24-094087","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-094087","line_url":"/filing/0000950170-24-094087#line-1","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001804460","owner_name":"Paulson Richard A.","owner_display_name":"Paulson Richard A.","owner_url":"/insider/0001804460","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3608.0,"shares_display":"3,608","price_per_share":0.9299,"price_display":"0.93","price_state":"stated","total_value":3355.0792,"total_display":"3,355.08","total_whole":"3,355","shares_owned_after":1142881.0,"shares_owned_after_display":"1,142,881","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-06","filed_date":"2024-08-08","scope":"insider"},{"id":2305200,"accession":"0000950170-24-082417","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-082417","line_url":"/filing/0000950170-24-082417#line-1","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001804460","owner_name":"Paulson Richard A.","owner_display_name":"Paulson Richard A.","owner_url":"/insider/0001804460","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3616.0,"shares_display":"3,616","price_per_share":0.851,"price_display":"0.85","price_state":"stated","total_value":3077.216,"total_display":"3,077.22","total_whole":"3,077","shares_owned_after":1146489.0,"shares_owned_after_display":"1,146,489","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-05","filed_date":"2024-07-09","scope":"insider"},{"id":2037361,"accession":"0000950170-24-069856","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-069856","line_url":"/filing/0000950170-24-069856#line-1","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001804460","owner_name":"Paulson Richard A.","owner_display_name":"Paulson Richard A.","owner_url":"/insider/0001804460","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3592.0,"shares_display":"3,592","price_per_share":0.99,"price_display":"0.99","price_state":"stated","total_value":3556.08,"total_display":"3,556.08","total_whole":"3,556","shares_owned_after":1150105.0,"shares_owned_after_display":"1,150,105","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-04","filed_date":"2024-06-06","scope":"insider"},{"id":2081592,"accession":"0000950170-24-054686","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-054686","line_url":"/filing/0000950170-24-054686#line-1","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001804460","owner_name":"Paulson Richard A.","owner_display_name":"Paulson Richard A.","owner_url":"/insider/0001804460","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3576.0,"shares_display":"3,576","price_per_share":1.13,"price_display":"1.13","price_state":"stated","total_value":4040.88,"total_display":"4,040.88","total_whole":"4,041","shares_owned_after":1153697.0,"shares_owned_after_display":"1,153,697","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-06","filed_date":"2024-05-07","scope":"insider"},{"id":2983993,"accession":"0000950170-24-042350","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-042350","line_url":"/filing/0000950170-24-042350#line-1","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001804460","owner_name":"Paulson Richard A.","owner_display_name":"Paulson Richard A.","owner_url":"/insider/0001804460","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3563.0,"shares_display":"3,563","price_per_share":1.29,"price_display":"1.29","price_state":"stated","total_value":4596.27,"total_display":"4,596.27","total_whole":"4,596","shares_owned_after":1157273.0,"shares_owned_after_display":"1,157,273","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-04","filed_date":"2024-04-05","scope":"insider"},{"id":2587049,"accession":"0000950170-24-027153","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-027153","line_url":"/filing/0000950170-24-027153#line-1","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001804460","owner_name":"Paulson Richard A.","owner_display_name":"Paulson Richard A.","owner_url":"/insider/0001804460","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3573.0,"shares_display":"3,573","price_per_share":1.3,"price_display":"1.30","price_state":"stated","total_value":4644.9,"total_display":"4,644.90","total_whole":"4,645","shares_owned_after":1160836.0,"shares_owned_after_display":"1,160,836","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-05","filed_date":"2024-03-06","scope":"insider"},{"id":2459020,"accession":"0000950170-24-025188","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-025188","line_url":"/filing/0000950170-24-025188#line-2","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001804460","owner_name":"Paulson Richard A.","owner_display_name":"Paulson Richard A.","owner_url":"/insider/0001804460","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19374.0,"shares_display":"19,374","price_per_share":1.2,"price_display":"1.20","price_state":"stated","total_value":23248.8,"total_display":"23,248.80","total_whole":"23,249","shares_owned_after":1164409.0,"shares_owned_after_display":"1,164,409","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-01","filed_date":"2024-03-04","scope":"insider"},{"id":2459019,"accession":"0000950170-24-025188","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-025188","line_url":"/filing/0000950170-24-025188#line-1","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001804460","owner_name":"Paulson Richard A.","owner_display_name":"Paulson Richard A.","owner_url":"/insider/0001804460","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":80470.0,"shares_display":"80,470","price_per_share":1.17,"price_display":"1.17","price_state":"stated","total_value":94149.9,"total_display":"94,149.90","total_whole":"94,150","shares_owned_after":1183783.0,"shares_owned_after_display":"1,183,783","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-29","filed_date":"2024-03-04","scope":"insider"},{"id":2733953,"accession":"0000950170-24-012824","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-012824","line_url":"/filing/0000950170-24-012824#line-1","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001804460","owner_name":"Paulson Richard A.","owner_display_name":"Paulson Richard A.","owner_url":"/insider/0001804460","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4012.0,"shares_display":"4,012","price_per_share":1.5865,"price_display":"1.59","price_state":"stated","total_value":6365.038,"total_display":"6,365.04","total_whole":"6,365","shares_owned_after":821453.0,"shares_owned_after_display":"821,453","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-06","filed_date":"2024-02-08","scope":"insider"},{"id":3018415,"accession":"0000950170-24-003177","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-003177","line_url":"/filing/0000950170-24-003177#line-1","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001804460","owner_name":"Paulson Richard A.","owner_display_name":"Paulson Richard A.","owner_url":"/insider/0001804460","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4114.0,"shares_display":"4,114","price_per_share":0.82,"price_display":"0.82","price_state":"stated","total_value":3373.48,"total_display":"3,373.48","total_whole":"3,373","shares_owned_after":783465.0,"shares_owned_after_display":"783,465","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-04","filed_date":"2024-01-08","scope":"insider"},{"id":8471376,"accession":"0001209191-23-057465","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-057465","line_url":"/filing/0001209191-23-057465#line-1","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001804460","owner_name":"Paulson Richard A.","owner_display_name":"Paulson Richard A.","owner_url":"/insider/0001804460","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3622.0,"shares_display":"3,622","price_per_share":0.79,"price_display":"0.79","price_state":"stated","total_value":2861.38,"total_display":"2,861.38","total_whole":"2,861","shares_owned_after":787579.0,"shares_owned_after_display":"787,579","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-04","filed_date":"2023-12-05","scope":"insider"},{"id":7999875,"accession":"0001209191-23-054626","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-054626","line_url":"/filing/0001209191-23-054626#line-1","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001804460","owner_name":"Paulson Richard A.","owner_display_name":"Paulson Richard A.","owner_url":"/insider/0001804460","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3606.0,"shares_display":"3,606","price_per_share":0.9203,"price_display":"0.92","price_state":"stated","total_value":3318.6018,"total_display":"3,318.60","total_whole":"3,319","shares_owned_after":791201.0,"shares_owned_after_display":"791,201","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-06","filed_date":"2023-11-07","scope":"insider"},{"id":8335149,"accession":"0001209191-23-052215","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-052215","line_url":"/filing/0001209191-23-052215#line-1","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001804460","owner_name":"Paulson Richard A.","owner_display_name":"Paulson Richard A.","owner_url":"/insider/0001804460","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3589.0,"shares_display":"3,589","price_per_share":1.27,"price_display":"1.27","price_state":"stated","total_value":4558.03,"total_display":"4,558.03","total_whole":"4,558","shares_owned_after":794807.0,"shares_owned_after_display":"794,807","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-10-04","filed_date":"2023-10-05","scope":"insider"},{"id":8064922,"accession":"0000950170-23-046721","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-23-046721","line_url":"/filing/0000950170-23-046721","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001804460","owner_name":"Paulson Richard A.","owner_display_name":"Paulson Richard A.","owner_url":"/insider/0001804460","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3622.0,"shares_display":"3,622","price_per_share":1.32982330204307,"price_display":"1.33","price_state":"stated","total_value":4816.62,"total_display":"4,816.62","total_whole":"4,817","shares_owned_after":798460.0,"shares_owned_after_display":"798,460","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-05","filed_date":"2023-09-06","scope":"insider","n_lines":2},{"id":7898844,"accession":"0001209191-23-045045","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-045045","line_url":"/filing/0001209191-23-045045#line-1","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001804460","owner_name":"Paulson Richard A.","owner_display_name":"Paulson Richard A.","owner_url":"/insider/0001804460","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3722.0,"shares_display":"3,722","price_per_share":1.72,"price_display":"1.72","price_state":"stated","total_value":6401.84,"total_display":"6,401.84","total_whole":"6,402","shares_owned_after":802018.0,"shares_owned_after_display":"802,018","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-07","filed_date":"2023-08-08","scope":"insider"},{"id":7835912,"accession":"0001209191-23-041635","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-041635","line_url":"/filing/0001209191-23-041635#line-1","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001804460","owner_name":"Paulson Richard A.","owner_display_name":"Paulson Richard A.","owner_url":"/insider/0001804460","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3538.0,"shares_display":"3,538","price_per_share":1.72,"price_display":"1.72","price_state":"stated","total_value":6085.36,"total_display":"6,085.36","total_whole":"6,085","shares_owned_after":805740.0,"shares_owned_after_display":"805,740","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-05","filed_date":"2023-07-06","scope":"insider"},{"id":8220921,"accession":"0001209191-23-035057","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-035057","line_url":"/filing/0001209191-23-035057#line-1","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001804460","owner_name":"Paulson Richard A.","owner_display_name":"Paulson Richard A.","owner_url":"/insider/0001804460","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3536.0,"shares_display":"3,536","price_per_share":2.2404,"price_display":"2.24","price_state":"stated","total_value":7922.0544,"total_display":"7,922.05","total_whole":"7,922","shares_owned_after":809278.0,"shares_owned_after_display":"809,278","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-05","filed_date":"2023-06-07","scope":"insider"},{"id":7961916,"accession":"0000899243-23-012353","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-23-012353","line_url":"/filing/0000899243-23-012353#line-1","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001804460","owner_name":"Paulson Richard A.","owner_display_name":"Paulson Richard A.","owner_url":"/insider/0001804460","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3805.0,"shares_display":"3,805","price_per_share":3.3516,"price_display":"3.35","price_state":"stated","total_value":12752.838,"total_display":"12,752.84","total_whole":"12,753","shares_owned_after":812814.0,"shares_owned_after_display":"812,814","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-04","filed_date":"2023-05-05","scope":"insider"},{"id":8183136,"accession":"0001209191-23-023378","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-023378","line_url":"/filing/0001209191-23-023378#line-1","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001804460","owner_name":"Paulson Richard A.","owner_display_name":"Paulson Richard A.","owner_url":"/insider/0001804460","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3497.0,"shares_display":"3,497","price_per_share":3.97,"price_display":"3.97","price_state":"stated","total_value":13883.09,"total_display":"13,883.09","total_whole":"13,883","shares_owned_after":816619.0,"shares_owned_after_display":"816,619","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-04","filed_date":"2023-04-05","scope":"insider"},{"id":8288908,"accession":"0001209191-23-016700","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-016700","line_url":"/filing/0001209191-23-016700#line-1","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001804460","owner_name":"Paulson Richard A.","owner_display_name":"Paulson Richard A.","owner_url":"/insider/0001804460","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3506.0,"shares_display":"3,506","price_per_share":3.16,"price_display":"3.16","price_state":"stated","total_value":11078.96,"total_display":"11,078.96","total_whole":"11,079","shares_owned_after":820116.0,"shares_owned_after_display":"820,116","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-06","filed_date":"2023-03-07","scope":"insider"},{"id":8071318,"accession":"0001209191-23-014838","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-014838","line_url":"/filing/0001209191-23-014838#line-2","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001804460","owner_name":"Paulson Richard A.","owner_display_name":"Paulson Richard A.","owner_url":"/insider/0001804460","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":33033.0,"shares_display":"33,033","price_per_share":3.0292,"price_display":"3.03","price_state":"stated","total_value":100063.5636,"total_display":"100,063.56","total_whole":"100,064","shares_owned_after":823622.0,"shares_owned_after_display":"823,622","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-01","filed_date":"2023-03-02","scope":"insider"},{"id":8034865,"accession":"0001209191-23-007772","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-007772","line_url":"/filing/0001209191-23-007772#line-1","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001804460","owner_name":"Paulson Richard A.","owner_display_name":"Paulson Richard A.","owner_url":"/insider/0001804460","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3950.0,"shares_display":"3,950","price_per_share":3.4,"price_display":"3.40","price_state":"stated","total_value":13430.0,"total_display":"13,430.00","total_whole":"13,430","shares_owned_after":604655.0,"shares_owned_after_display":"604,655","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-06","filed_date":"2023-02-08","scope":"insider"},{"id":8069684,"accession":"0001209191-23-002052","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-002052","line_url":"/filing/0001209191-23-002052#line-1","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001804460","owner_name":"Paulson Richard A.","owner_display_name":"Paulson Richard A.","owner_url":"/insider/0001804460","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3922.0,"shares_display":"3,922","price_per_share":3.27,"price_display":"3.27","price_state":"stated","total_value":12824.94,"total_display":"12,824.94","total_whole":"12,825","shares_owned_after":608605.0,"shares_owned_after_display":"608,605","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-04","filed_date":"2023-01-05","scope":"insider"},{"id":6701071,"accession":"0001209191-22-060041","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-060041","line_url":"/filing/0001209191-22-060041#line-1","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001804460","owner_name":"Paulson Richard A.","owner_display_name":"Paulson Richard A.","owner_url":"/insider/0001804460","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3490.0,"shares_display":"3,490","price_per_share":5.17,"price_display":"5.17","price_state":"stated","total_value":18043.3,"total_display":"18,043.30","total_whole":"18,043","shares_owned_after":612527.0,"shares_owned_after_display":"612,527","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-05","filed_date":"2022-12-06","scope":"insider"},{"id":6457793,"accession":"0001209191-22-056152","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-056152","line_url":"/filing/0001209191-22-056152#line-1","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001804460","owner_name":"Paulson Richard A.","owner_display_name":"Paulson Richard A.","owner_url":"/insider/0001804460","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3493.0,"shares_display":"3,493","price_per_share":4.54,"price_display":"4.54","price_state":"stated","total_value":15858.22,"total_display":"15,858.22","total_whole":"15,858","shares_owned_after":616017.0,"shares_owned_after_display":"616,017","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-04","filed_date":"2022-11-08","scope":"insider"},{"id":6497614,"accession":"0001209191-22-052726","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-052726","line_url":"/filing/0001209191-22-052726#line-1","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001804460","owner_name":"Paulson Richard A.","owner_display_name":"Paulson Richard A.","owner_url":"/insider/0001804460","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3488.0,"shares_display":"3,488","price_per_share":5.87,"price_display":"5.87","price_state":"stated","total_value":20474.56,"total_display":"20,474.56","total_whole":"20,475","shares_owned_after":619510.0,"shares_owned_after_display":"619,510","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-04","filed_date":"2022-10-05","scope":"insider"},{"id":6457089,"accession":"0001209191-22-049255","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-049255","line_url":"/filing/0001209191-22-049255","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001804460","owner_name":"Paulson Richard A.","owner_display_name":"Paulson Richard A.","owner_url":"/insider/0001804460","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3479.0,"shares_display":"3,479","price_per_share":5.230120954297212,"price_display":"5.23","price_state":"stated","total_value":18195.5908,"total_display":"18,195.59","total_whole":"18,196","shares_owned_after":622998.0,"shares_owned_after_display":"622,998","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-08","filed_date":"2022-09-09","scope":"insider","n_lines":2},{"id":6547876,"accession":"0001209191-22-044561","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-044561","line_url":"/filing/0001209191-22-044561#line-1","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001804460","owner_name":"Paulson Richard A.","owner_display_name":"Paulson Richard A.","owner_url":"/insider/0001804460","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2314.0,"shares_display":"2,314","price_per_share":4.48,"price_display":"4.48","price_state":"stated","total_value":10366.72,"total_display":"10,366.72","total_whole":"10,367","shares_owned_after":626477.0,"shares_owned_after_display":"626,477","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-04","filed_date":"2022-08-05","scope":"insider"},{"id":6612755,"accession":"0001209191-22-041774","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-041774","line_url":"/filing/0001209191-22-041774#line-1","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001804460","owner_name":"Paulson Richard A.","owner_display_name":"Paulson Richard A.","owner_url":"/insider/0001804460","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2115.0,"shares_display":"2,115","price_per_share":5.1762,"price_display":"5.18","price_state":"stated","total_value":10947.663,"total_display":"10,947.66","total_whole":"10,948","shares_owned_after":628791.0,"shares_owned_after_display":"628,791","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-08","filed_date":"2022-07-11","scope":"insider"},{"id":6318519,"accession":"0000899243-22-021477","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-021477","line_url":"/filing/0000899243-22-021477#line-1","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001804460","owner_name":"Paulson Richard A.","owner_display_name":"Paulson Richard A.","owner_url":"/insider/0001804460","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2542.0,"shares_display":"2,542","price_per_share":5.7602,"price_display":"5.76","price_state":"stated","total_value":14642.4284,"total_display":"14,642.43","total_whole":"14,642","shares_owned_after":630906.0,"shares_owned_after_display":"630,906","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-07","filed_date":"2022-06-08","scope":"insider"},{"id":6496477,"accession":"0001209191-22-027344","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-027344","line_url":"/filing/0001209191-22-027344","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001804460","owner_name":"Paulson Richard A.","owner_display_name":"Paulson Richard A.","owner_url":"/insider/0001804460","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":28502.0,"shares_display":"28,502","price_per_share":6.227959546698477,"price_display":"6.23","price_state":"stated","total_value":177509.303,"total_display":"177,509.30","total_whole":"177,509","shares_owned_after":633448.0,"shares_owned_after_display":"633,448","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-04","filed_date":"2022-05-05","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":46,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":46,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":46},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001503802","name":"Karyopharm Therapeutics Inc.","url":"/issuer/0001503802","role":"Director, Officer (President and CEO)","n_filings":42,"first_seen":"2022-05-05","last_seen":"2026-05-15"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001804460","retrieved_at":"2026-08-24T06:47:29+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}